#1356 2007 · Fujifilm · Chemicals & consumer goods
Fujifilm outlived the death of film by selling its film chemistry as skincare
问题
Digital cameras were erasing the photographic film market — Fujifilm's core business — by double digits a year
背景
In the 2000s digital photography destroyed the film market with brutal speed — demand peaked in 2000 and then fell by double digits annually. Kodak, the industry's other giant, rode the decline into bankruptcy in 2012. Fujifilm faced the same terminal diagnosis with the same assets: factories, chemists and seven decades of research organised around a product the world was abandoning.
The trap in that situation is to define yourself by the product and defend it — cut costs, milk the decline, bet on a digital-camera business where you own no advantage. Fujifilm's leadership under Shigetaka Komori instead audited what the company actually knew, independent of what it sold: photographic film is a ~20-micron gelatin coating, gelatin is collagen, and keeping colour photos from fading is applied antioxidation chemistry.
换别人会怎么做
Fight the decline: cut film costs to harvest cash, pivot the brand into digital cameras and printing where the incumbents' advantages didn't transfer, and diversify by acquisition into unrelated growth sectors. That is roughly Kodak's playbook, and it ended in Chapter 11.
他们看到了什么
Film was never the asset — the asset was collagen handling, nano-dispersion and antioxidation chemistry that film happened to need. Skin needs the same three things, so the dying product's science became a growing product's ingredient list.
那一手
Fujifilm re-read its film technology portfolio as ingredients for other industries and in 2007 launched Astalift, a skincare line built directly on film science: collagen handling from seventy years of making film base, nano-emulsification from getting light-sensitive compounds into uniform coatings, and antioxidants — notably astaxanthin — proven in stopping photographic dye from oxidising, redeployed against the oxidation that ages skin. The same audit spun film chemistry into pharmaceuticals, LCD panel films and regenerative medicine, with cosmetics as the consumer-facing proof that the company's real asset was the chemistry, not the film cartridge.
为什么管用
Capabilities outlive products because they are inputs, not outputs: the chemistry that keeps a photo from fading is genuinely the chemistry of oxidative aging, so Fujifilm entered cosmetics with decades of accumulated research its new competitors lacked, rather than as a me-too entrant. The consumer logic also carried — a film company selling skincare sounds absurd until the mechanism is explained, and the explanation itself ('photos fade the way skin ages') is the marketing. Because the transfer ran on existing labs and patents, the pivot's cost was mostly the courage to re-describe the company.
值了多少
Astalift became a top-selling Japanese anti-aging line and expanded across Asia; healthcare and materials now outweigh imaging in Fujifilm's revenue, while Kodak went bankrupt.
什么时候会失灵
It fails when the capability audit flatters instead of measures — most companies list 'quality' and 'brand' rather than transferable technical depth, and enter categories where incumbents out-know them. It also fails if the new category can't absorb the cost structure (industrial chemists priced into face cream works only at premium positioning), or if leadership pivots too late, after the dying product has consumed the cash the transfer needed.
后来呢
The canonical case of surviving product death by re-inventorying competence: 'what do we know' beat 'what do we sell', taught against Kodak's collapse in strategy courses worldwide.
资料来源
- [1]Fujifilm Finds New Life in CosmeticsNippon.com, 2018nippon.com
- [2]Why Kodak Died and Fujifilm Thrived: A Tale of Two Film CompaniesPetaPixel, 2018petapixel.com
- [3]Fujifilm: surviving digital through diversification into cosmeticsHarvard Business School RCTOM, 2017aiinstitute.hbs.edu